Cargando…

Comparison of the predictive value of anthropometric indicators for the risk of benign prostatic hyperplasia in southern China

This study aimed to compare the predictive value of six selected anthropometric indicators for benign prostatic hyperplasia (BPH). Males over 50 years of age who underwent health examinations at the Health Management Center of the Second Xiangya Hospital, Central South University (Changsha, China) f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Meng-Jun, Yang, Yan-Yi, Chen, Can, Luo, Rui-Xiang, Wen, Chu-Qi, Li, Yang, Zeng, Ling-Peng, Li, Xiang-Yang, Yin, Zhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069681/ https://www.ncbi.nlm.nih.gov/pubmed/36018066 http://dx.doi.org/10.4103/aja202249

Ejemplares similares

Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men
por: Yin, Zhuo, et al.
Publicado: (2015)

Value for Money in Disease Management of Benign Prostatic Hyperplasia
por: Curtiss, Frederic R.
Publicado: (2004)

Benign Prostatic Hyperplasia
Publicado: (2015)

Metabolic syndrome and benign prostatic hyperplasia: An update
por: Ngai, Ho-Yin, et al.
Publicado: (2017)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer
por: Yang, Lu, et al.
Publicado: (2015)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Investigation of Lymphocyte Subsets in Peripheral Blood of Patients with Benign Prostatic Hyperplasia
por: Li, Ming, et al.
Publicado: (2021)

Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
por: Zhang, Bo, et al.
Publicado: (2021)

Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia
por: Fu, Shi, et al.
Publicado: (2017)

The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia
por: Cakir, Suleyman Sami, et al.
Publicado: (2018)

Risk factors for bladder calculi in patients with benign prostatic hyperplasia
por: Huang, Wei, et al.
Publicado: (2017)

Frailty as a risk marker of adverse lower urinary symptom outcomes in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate
por: Ren, Xiang, et al.
Publicado: (2023)

LILRA3 Is Associated with Benign Prostatic Hyperplasia Risk in a Chinese Population
por: Jiao, Yang, et al.
Publicado: (2013)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity
por: Fu, Shi, et al.
Publicado: (2017)

Assessment of the utility of platelet indices to diagnose clinical benign prostatic hyperplasia in dogs
por: Hosseinpour, Hediyeh, et al.
Publicado: (2022)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
por: Abotsi, Ebenezer, et al.
Publicado: (2022)

Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
por: Jin, Wei, et al.
Publicado: (2020)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Efficacy and safety of transurethral split of prostate for benign prostatic hyperplasia: a meta-analysis
por: Huang, Yiyu, et al.
Publicado: (2020)

The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia
por: Liu, Jiang, et al.
Publicado: (2023)

Laparoscopic simple prostatectomy with prostatic urethra preservation for benign prostatic hyperplasia
por: Xing, Nianzeng, et al.
Publicado: (2012)

Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis
por: Zhang, Xingming, et al.
Publicado: (2016)

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)
por: Zeng, Xian-Tao, et al.
Publicado: (2022)

Prostatic anatomical parameters correlate with clinical characteristics suggestive of benign prostatic hyperplasia
por: Tian, Ye, et al.
Publicado: (2020)

Korean clinical practice guideline for benign prostatic hyperplasia
por: Yeo, Jeong Kyun, et al.
Publicado: (2016)

Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study
por: Wu, Lan, et al.
Publicado: (2019)

AB067. Transurethral endoscopic treatment of benign prostatic hyperplasia
por: Meng, Qingjun, et al.
Publicado: (2017)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Changes of resistance indices after medication in benign prostatic hyperplasia: a prospective study
por: Park, Dong Jin, et al.
Publicado: (2023)

The effectiveness and safety of moxibustion for treating benign prostatic hyperplasia: A protocol for systematic review and meta-analysis
por: Chen, Hui, et al.
Publicado: (2020)

Exploring the effects and mechanism of peony pollen in treating benign prostatic hyperplasia
por: Mu, Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dh0u4po1r6ir6vpbukngjrm4f6